Skip to main content

Table 3 Meta-analysis the association of CTSD C224T polymorphism with APOEϵ4 carrier in AD

From: Lack of association between cathepsin D C224T polymorphism and Alzheimer’s disease risk: an update meta-analysis

Comparison

Population

No. of studies

Test of association

Mode

Test of heterogeneity

   

OR

95% CI

P Value

 

x 2

PQ Value

I2

APOEϵ4 noncarriers

CT + TT vs. CC

Overall

10

1.139

0.844–1.539

0.395

R

19.28

0.023

53.3

 

Asian

3

0.73

0.390–1.365

0.324

F

5.81

0.055

65.5

 

Caucasian

7

1.212

0.998–1.472

0.052

F

11.86

0.065

49.4

APOEϵ4 carriers

CT + TT vs. CC

Overall

10

1.267

0.979–1.641

0.072

F

10.89

0.283

17.4

 

Asian

3

1.273

0.511–3.184

0.604

F

0.01

0.995

0.0

T carriers

Caucasian

7

1.267

0.979–1.641

0.085

F

10.88

0.092

44.9

APOEϵ4(+) vs. APOEϵ4(–)

Overall

10

4.532

2.755–7.455

0.000

R

18.16

0.033

50.4

 

Asian

3

7.913

2.632–23.785

0.000

F

0.20

0.904

0.0

 

Caucasian

7

4.134

2.338–7.310

0.000

R

15.58

0.016

61.5

T noncarriers

         

APOEϵ4(+) vs. APOEϵ4(–)

Overall

10

4.193

3.096–5.679

0.000

R

43.54

0.000

79.3

 

Asian

3

4.217

2.333–7.620

0.000

R

6.88

0.032

70.9

 

Caucasian

7

4.195

2.888–6.093

0.000

R

35.89

0.000

83.3

  1. OR, odds ratio; CI, confidence intervals; R, random effects model; F, fixed effects model.